Latest Shinya Yamanaka Stories
LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology or Medicine in the Superior Court of California, County of San Francisco. The lawsuit filed...
LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology or Medicine in the Superior Court of California, County of San Francisco. The lawsuit filed...
Organ Regeneration Noted As Top Priority in 2013 US Presidential State of the Union Address LOS ANGELES, May 15, 2013 /PRNewswire/ -- On May 8, 2013, Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life and medical scientist who is believed to be the only person who has patented the technology for direct regeneration of damaged organs has filed a lawsuit against Dr. Shinya Yamanaka, one of the winners of the 2012 Nobel Prize in Physiology...
redOrbit Staff & Wire Reports - Your Universe Online For the first time ever, researchers have been able to develop a maturation-based “disease-in-a-dish” model for an inherited heart ailment – a discovery that will help researchers study and test new therapies for the condition. Patients suffering from the condition, which is known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C), typically do not become aware that they have a heart problem until they are...
LOS ANGELES, Dec. 6, 2012 /PRNewswire/ -- Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life scientist and medical scientist, has filed a lawsuit today against The Nobel Assembly at Karolinska Institutet, a Swedish corporation, aka, Nobelforsamlingen. The Nobel Assembly at Karolinska Institutet is a body which awards the Nobel Prize in Physiology or Medicine. The suit filed in Superior Court of the State of California, Orange County...
Scientist at St. Jude is recipient of 2012 Meyenburg Cancer Research Award MEMPHIS, Tenn., Nov. 28, 2012 /PRNewswire-USNewswire/ -- Charles Mullighan, MBBS(Hons), MSc, M.D., an associate member at St. Jude Children's Research Hospital, is the 2012 recipient of the Meyenburg Cancer Research Award from The Meyenburg Foundation in Germany for achievements in the field of cancer research and medicine. The Meyenburg Foundation acknowledges excellent scientific accomplishments in the...
NEW YORK, Oct. 9, 2012 /PRNewswire/ -- Today, The New York Stem Cell Foundation (NYSCF) will award a Japanese scientist with the NYSCF - Robertson Prize for his extraordinary achievements in translational stem cell research. This award will go to Kazutoshi Takahashi, PhD, Lecturer, Center for iPS Cell Research and Application (CiRA) at Kyoto University, for his vital contribution to induced pluripotent stem (iPS) cell derivation. Dr. Takahashi was lead author on a series of...
Lawrence LeBlond for redOrbit.com - Your Universe Online Stem cell research has been a controversial, yet important advance in science and medicine for decades. Scientific research has been carried out in numerous areas pertaining to stem cells, and the work of two such researchers in the field have caught the eye of the most prestigious awards organization in the world. Britain’s Sir John Gurdon and Japan’s Shinya Yamanaka were both awarded the 2012 Nobel Prize for Medicine thanks...
Environmental factors key to successful growth of stem cells Scientists at the Gladstone Institutes have discovered that environmental factors critically influence the growth of a type of stem cell--called an iPS cell--that is derived from adult skin cells. This discovery offers newfound understanding of how these cells form, while also advancing science closer to stem cell-based therapies to combat disease. Researchers in the laboratory of Gladstone Senior Investigator Shinya Yamanaka,...
CARLSBAD, Calif., June 15, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that it has deepened its commitment to stem cell research and its customers by signing a non-exclusive agreement with iPS Academia Japan for its induced pluripotent stem (iPS) cell patent portfolio. The worldwide license will enable Life Technologies, a leading provider of innovative life science solutions, to expand its range of products and services for the iPS cell...
